Treatment of cerebral gliomas with the GliaSite® Radiation Therapy System has been performed in the United States since 2001. The procedure assumes the use of a spherical unsealed source containing 125I in liquid form. The amount of the activities utilized (GBq) is such that enacting appropriate radiation safety measures for the patient and personnel as prescribed by law and standards of good practice is a necessity. Dosimetry also requires special attention given the low energy of the radioisotope employed in therapy. In this study, the operative methods and results of radiation protection and dosimetric measurements performed on 10 patients in treatment with this system within our Institute between 2006 and 2007 are described.
|Number of pages||9|
|Publication status||Published - Dec 2007|
- Iodine 125
- Radiation safety
ASJC Scopus subject areas